Siguazodan

Siguazodan
Names
	IUPAC name 1-Cyano-2-methyl-3-[4-(4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl)phenyl]guanidine
Identifiers
CAS Number	115344-47-3 ;
3D model (JSmol)	Interactive image;
ChEBI	CHEBI:91791;
ChEMBL	ChEMBL1256712;
ChemSpider	65101;
ECHA InfoCard	100.162.222
EC Number	634-221-4;
PubChem CID	72124;
UNII	5E4UI00UQJ;
CompTox Dashboard (EPA)	DTXSID0045202 ;
	InChI InChI=1S/C14H16N6O/c1-9-7-12(21)19-20-13(9)10-3-5-11(6-4-10)18-14(16-2)17-8-15/h3-6,9H,7H2,1-2H3,(H,19,21)(H2,16,17,18) Key: NUHPODZZKHQQET-UHFFFAOYSA-N;
	SMILES CC1CC(=O)NN=C1C2=CC=C(C=C2)NC(=NC)NC#N;
Properties
Chemical formula	C14H16N6O
Molar mass	284.323 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Siguazodan is a phosphodiesterase inhibitor.^[1]

References

^ Sosroseno, W; Sugiatno, E (2008). "Cyclic-AMP-dependent proliferation of a human osteoblast cell line (HOS cells) induced by hydroxyapatite: Effect of exogenous nitric oxide". Acta Biomedica. 79 (2): 110–6. PMID 18788505.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.